Prudentbio is pioneering a novel plant-based expression platform for the efficient production of humanized antibodies with customized glycosylation profiles. Designed to integrate seamlessly with existing agricultural practices, our platform dramatically reduces production costs compared to traditional mammalian and other expression systems. This enables scalable, cost-effective manufacturing of highly specific and precisely glycosylated antibodies. Our mission is to harness this technology to advance next-generation diagnostic solutions for infectious diseases.